Be sure to check our sister interview main ratings news website

Deltex Medical Group plc is in the April edition of the British Journal of Anaesthesia

Deltex Medical Group plc (LON:DEMG), the global leader in Oesophageal Doppler Monitoring (“ODM”), announced today that it intends to release its results for the year ended 31 December 2017 on 9 May 2018.

Further to the announcement of the online publication of the results of the FEDORA trial on 1 March 2018, the Company notes that the study was included in the April print edition of the British Journal of Anaesthesia.

A recorded lecture on the FEDORA trial by Professor Monty Mythen is available at no charge at https://www.topmedtalk.com/journal-club-the-fedora-trial/

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    Deltex Medical Group Plc

    More articles like this

    Deltex Medical Group Plc

    Deltex Medical Group plc “outperforms in the USA”

    9th June 2016

    Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring (“ODM”), has told DirectorsTalk that it has added two additional accounts to its platform programme in the USA. The first account, the sixth

    Deltex Medical Group Plc

    Deltex Medical Group plc “Two new hospital accounts”

    5th April 2016

    Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring (“ODM”), has told DirectorsTalk that it has added two new hospital accounts to its platform programme in the USA.   The first new

    © 2023 – DirectorsTalk. All rights reserved. Reproduction in whole or in part, in any form or medium without express written permission is prohibited.